Rather than focusing solely on carbon emissions, chemical engineers at Texas A&M are emphasizing the idea of circularity, where CO2 becomes a resource.

New research from Aalborg University reveals that poor sleep can increase pain sensitivity in the nervous system. Women react particularly strongly to sleep disturbances, and this might open up a new path in the treatment of chronic pain.

Could robots help those with mobility issues make a pizza? With support from the National Science Foundation, a team of Virginia Tech mechanical engineers are using robotic grippers and artificial intelligence to make that idea a reality.

Glioma is an aggressive and malignant brain tumor with a poor prognosis, accounting for nearly half of all primary malignant brain tumors. Current treatments have limited efficacy and are often accompanied by side effects. Furthermore, the genetic diversity within glioma complicates the development of targeted therapies, warranting more research on the topic.

Metabolic dysfunction-associated steatotic liver disease (MASLD), a multifactorial disease that encompasses a spectrum of pathological conditions, ranging from simple steatosis, metabolic dysfunction-associated steatohepatitis (MASH), and fibrosis/cirrhosis, is associated with increased mortality. However, there are currently no standard diagnostic markers or effective treatments. Hence, there is an urgent need to elucidate the pathogenesis of MASLD to identify viable therapeutic targets.

Promoting the acceptance of clinical studies about traditional Chinese medicine (TCM) interventions by the international community is a key strategy for internationalization of TCM. However, the complexities of TCM interventions – in terms of its theories, practice patterns, and components – pose significant challenges in designing and implementing clinical studies that are well accepted by the international community. This article summarized the current status of clinical studies about TCM interventions published in international journals, explored underlying barriers to promoting their global acceptance, and discussed potential strategies for future development.

In the paper published on Science of Traditional Chinese Medicine(STCM), the authors utilized synthetic biology technology to create the first artificial herbal cell (AHC) based on a traditional Chinese medicine (TCM) formulation: Compound Danshen Yeast 1.0. This breakthrough provides foundational technology for producing TCM formulations through one-step fermentation using simple carbon sources like glucose and ethanol—eliminating the need for wild harvesting or cultivation of medicinal herbs. By harnessing synthetic biology, the team reprogrammed a single yeast strain to simultaneously synthesize three classes of active ingredients—notoginsenosides (protopanaxadiol), tanshinone diterpenoid (miltiradiene), and borneol.